Vaccinogen

About Vaccinogen

Vaccinogen is a biotechnology company focused on developing personalized vaccines to reduce cancer recurrence by harnessing the body's immune system. The company's flagship product, OncoVAX, is designed to help the immune system identify and destroy residual tumor cells post-surgery. Vaccinogen primarily serves pharmaceutical companies and investment groups interested in innovative cancer treatments. Operating within the biotechnology and healthcare markets, Vaccinogen's business model revolves around the development and commercialization of its proprietary vaccines. Revenue is generated through partnerships, licensing agreements, and direct sales of its vaccine products. The company aims to revolutionize cancer treatment by offering a tailored approach that considers the unique genetic makeup of each tumor, thereby improving patient outcomes and reducing the likelihood of cancer returning.